2025-04-01 - Analysis Report
## Albemarle Corp (ALB) Stock Report

**0. Summary of Key Figures:**

* **Cumulative Return (ALB):** -28.72%
* **Cumulative Return (VOO):** 91.19%
* **Return Difference (ALB vs VOO):** -119.9%
* **Relative Divergence:** 2.0% (indicating ALB's performance is relatively near the lower bound compared to its historical performance against VOO)
* **Current Price:** $74.75
* **Last Market Price:** $71.82 (down $0.51 from the previous close)
* **5-Day Moving Average:** $76.65
* **20-Day Moving Average:** $75.42
* **60-Day Moving Average:** $81.46
* **RSI:** 49.17
* **PPO:** 0.44
* **Market Risk Indicator (MRI):** 0.43 (Medium Risk)
* **Expected Return (Long-term):** 2938.6% (significantly exceeding S&P 500)


**1. Albemarle Corp (ALB) Overview and Performance Comparison:**

Albemarle Corp is a leading global producer of lithium and bromine-based specialty chemicals.

The provided data shows a significant underperformance of ALB (-28.72%) compared to the S&P 500 (VOO) which returned 91.19%. The difference is -119.9%, placing its current relative divergence at 2.0% within its historical range of performance against the S&P 500.  The alpha and beta values fluctuate significantly year-over-year, indicating high volatility and sensitivity to market movements.  There are periods of strong outperformance (e.g., 2019-2021) and significant underperformance (e.g., 2022-2024).  This suggests the company's performance is highly cyclical and dependent on market conditions within the lithium and bromine sectors.

**2. Recent Price Movement:**

The current price ($74.75) is below the 5-day ($76.65) and 20-day ($75.42) moving averages, suggesting a short-term downtrend.  It is also significantly below the 60-day moving average ($81.46), indicating a more prolonged downward trend. The recent price drop of $0.51 reflects a minor negative shift.

**3. Technical Indicators and Expected Return:**

The RSI of 49.17 is near the neutral level (50), indicating neither overbought nor oversold conditions. The PPO of 0.44 suggests a potential bullish momentum, although this should be interpreted in conjunction with other indicators. The negative relative divergence (-0.8) indicates a recent short-term decline. The high expected return of 2938.6% over the long term should be viewed cautiously, as it is based on assumptions regarding future market conditions and the company's performance.  Given the high volatility displayed in previous years, this projection is highly uncertain.

**4. Recent Earnings Analysis:**

| Date       | EPS     | Revenue      |
|------------|---------|--------------|
| 2024-11-06 | -9.45   | $1.35B       |
| 2024-07-31 | -1.96   | $1.43B       |
| 2024-05-01 | -0.08   | $1.36B       |
| 2023-11-01 | 2.58    | $2.31B       |
| 2024-11-06 | 2.58    | $2.31B       | *(This appears to be a duplicate entry)*


The most recent earnings show a significant decline in profitability, with substantial losses in Q3 and Q4 2024. This sharp negative swing contrasts with a positive EPS in the prior quarter (Q4 2023). The revenue figures show some consistency, though a decrease is observable from Q4 2023 to subsequent quarters.  Further investigation into the causes of this dramatic shift in profitability is required.  There is a duplicated entry which needs to be clarified.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31  | $1.23B   | 11.22%        |
| 2024-09-30  | $1.35B   | -7.68%        |
| 2024-06-30  | $1.43B   | -0.74%        |
| 2024-03-31  | $1.36B   | 2.86%         |
| 2023-12-31  | $2.36B   | -29.88%       |


**Capital and Profitability:**

| Quarter     | Equity   | ROE          |
|-------------|----------|--------------|
| 2024-12-31  | $9.96B   | 0.76%        |
| 2024-09-30  | $10.24B  | -10.44%       |
| 2024-06-30  | $11.22B  | -1.68%       |
| 2024-03-31  | $11.53B  | 0.02%        |
| 2023-12-31  | $9.41B   | -6.56%       |

The financial data reveals a concerning trend of declining profitability and fluctuating equity.  The significant drop in profit margins and ROE in recent quarters, coupled with the negative EPS figures, raises serious concerns about the company's financial health.  The substantial loss in profit margin from 2.86% to -7.68% and -29.88% raises significant questions about its operational efficiency and market position.


**6. Overall Analysis:**

ALB's recent performance has been significantly weaker than the broader market, as reflected by its negative cumulative return compared to VOO.  While some technical indicators suggest potential for a short-term bounce, the underlying financial picture is alarming.  The substantial losses and declining profitability raise serious questions about the company's long-term outlook. The projected high long-term expected return should be treated with extreme skepticism given the current financial distress and volatility displayed in the past few years. Further investigation is needed to understand the factors driving the recent decline in profitability and the companyâ€™s strategic response.  Investors should proceed with caution and conduct thorough due diligence before making any investment decisions.
